A
Ann M. Turnley
Researcher at University of Melbourne
Publications - 101
Citations - 5483
Ann M. Turnley is an academic researcher from University of Melbourne. The author has contributed to research in topics: Neural stem cell & Neurogenesis. The author has an hindex of 41, co-authored 101 publications receiving 5185 citations. Previous affiliations of Ann M. Turnley include Royal Adelaide Hospital & Royal Melbourne Hospital.
Papers
More filters
Journal ArticleDOI
Axonal Regeneration and Lack of Astrocytic Gliosis in EphA4-Deficient Mice
TL;DR: It is demonstrated that adult mice lacking EphA4 (-/-), a molecule essential for correct guidance of spinal cord axons during development, exhibit axonal regeneration and functional recovery after spinal cord hemisection.
Journal ArticleDOI
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
Annelies Van Hoecke,Lies Schoonaert,Robin Lemmens,Mieke Timmers,Kim A. Staats,Angela S. Laird,Elke Peeters,Thomas Philips,An Goris,Bénédicte Dubois,Peter M. Andersen,Ammar Al-Chalabi,Vincent Thijs,Ann M. Turnley,Paul W.J. van Vught,Jan H. Veldink,Orla Hardiman,Ludo Van Den Bosch,Paloma Gonzalez-Perez,Philip Van Damme,Robert H. Brown,Leonard H. van den Berg,Wim Robberecht +22 more
TL;DR: In this article, a zebrafish model of ALS and identified Epha4, a receptor in the ephrin axonal repellent system, as a modifier of the disease phenotype in fish, rodents and humans.
Journal ArticleDOI
Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system.
Ann M. Turnley,David Stapleton,Richard J. Mann,Lee A. Witters,Bruce E. Kemp,Perry F. Bartlett +5 more
TL;DR: Preference nuclear localization of the α2, β1, and γ1 subunits suggests new functions of the AMP‐activated protein kinase, and the different expression patterns and cellular localization between the two catalytic subunits α1 and α2 point to different physiological roles.
Journal ArticleDOI
LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival
Helmut Butzkueven,Jian Guo Zhang,Merja Soilu-Hanninen,Hubertus Hochrein,Fiona Chionh,Kylie Shipham,Ben Emery,Ann M. Turnley,Steven Petratos,Matthias Ernst,Perry F. Bartlett,Trevor J. Kilpatrick +11 more
TL;DR: This study shows that the neurotrophic cytokine leukemia inhibitory factor (LIF) directly prevents oligodendrocyte death in animal models of MS and demonstrates that this therapeutic effect complements endogenous LIF receptor signaling, which already serves to limit oligodendedrocytes loss during immune attack.
Journal ArticleDOI
Neural precursor differentiation into astrocytes requires signaling through the leukemia inhibitory factor receptor
Simon A. Koblar,Ann M. Turnley,Brendan J. Classon,Kate Reid,Carol B. Ware,Surinda S Cheema,Mark Murphy,Perry F. Bartlett +7 more
TL;DR: It is shown that neural precursors isolated from the developing forebrain of mice that are deficient in the gene for the low-affinity leukemia inhibitory factor receptor (LIFR-/-) fail to generate astrocytes expressing glial fibrillary acidic protein (GFAP) when cultured in vitro, and indeed the LIF-deficient animals show a significant reduction in the number of GFAP cells in the hippocampus.